Studying Tissue Samples From Women Who Underwent Chemotherapy for Lymph Node-Positive Stage II or Stage IIIA Breast Cancer on Clinical Trial CLB-9741 or CLB-9344

NCT00897026 · clinicaltrials.gov ↗

COMPLETED

Status

1195

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: cyclophosphamide
DRUG: doxorubicin hydrochloride
DRUG: paclitaxel
GENETIC: fluorescence in situ hybridization
OTHER: immunohistochemistry staining method

Sponsor

Alliance for Clinical Trials in Oncology

Collaborators

[object Object]